Screening for breast cancer

JG Elmore, K Armstrong, CD Lehman, SW Fletcher - Jama, 2005 - jamanetwork.com
ContextBreast cancer screening in community practices may be different from that in
randomized controlled trials. New screening modalities are becoming available …

An overview of prognostic factors for long-term survivors of breast cancer

I Soerjomataram, MWJ Louwman, JG Ribot… - Breast cancer research …, 2008 - Springer
Background Numerous studies have examined prognostic factors for survival of breast
cancer patients, but relatively few have dealt specifically with 10+-year survivors. Methods A …

[HTML][HTML] Mammography screening: A major issue in medicine

P Autier, M Boniol - European journal of cancer, 2018 - Elsevier
Breast cancer mortality is declining in most high-income countries. The role of
mammography screening in these declines is much debated. Screening impacts cancer …

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial

C Kuhl, S Weigel, S Schrading, B Arand… - Journal of Clinical …, 2010 - ascopubs.org
Purpose We investigated the respective contribution (in terms of cancer yield and stage at
diagnosis) of clinical breast examination (CBE), mammography, ultrasound, and quality …

MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study

CK Kuhl, S Schrading, HB Bieling, E Wardelmann… - The Lancet, 2007 - thelancet.com
Background Diagnosing breast cancer in its intraductal stage might be helpful to prevent the
development of invasive cancer. Our aim was to investigate the sensitivity with which ductal …

PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer

GC Wishart, EM Azzato, DC Greenberg… - Breast Cancer …, 2010 - Springer
Introduction The aim of this study was to develop and validate a prognostication model to
predict overall and breast cancer specific survival for women treated for early breast cancer …

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

DA Berry, C Cirrincione, IC Henderson, ML Citron… - Jama, 2006 - jamanetwork.com
ContextBreast cancer estrogen-receptor (ER) status is useful in predicting benefit from
endocrine therapy. It may also help predict which patients benefit from advances in adjuvant …

[图书][B] Clinical epidemiology: principles, methods, and applications for clinical research

DE Grobbee, AW Hoes - 2014 - books.google.com
Now updated with new data and examples throughout, Clinical Epidemiology: Principles,
Methods, and Applications for Clinical Research, Second Edition is a comprehensive …

Does utilization of screening mammography explain racial and ethnic differences in breast cancer?

R Smith-Bindman, DL Miglioretti, N Lurie… - Annals of internal …, 2006 - acpjournals.org
Background: Reasons for persistent differences in breast cancer mortality rates among
various racial and ethnic groups have been difficult to ascertain. Objective: To determine …

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

GC Wishart, CD Bajdik, E Dicks, E Provenzano… - British journal of …, 2012 - nature.com
Background: Predict (www. predict. nhs. uk) is an online, breast cancer prognostication and
treatment benefit tool. The aim of this study was to incorporate the prognostic effect of HER2 …